ClinicalTrials.gg
RecruitingNCT07854951HYP-SCOLUpdated Oct 2, 2026

Hypnosis for Pain and Nausea Reduction in Scoliosis Surgery: An Interventional Study

An interventional study of Hypnosis in Adolescent Idiopathic Scoliosis (AIS), sponsored by St. Olavs Hospital. Recruiting at 1 site in Norway. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by St. Olavs Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Nov 2025; still recruiting 11 months later.
Updated Oct 2, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
12 Years to 18 Years
Sex
All
01

Study summary

This study evaluates whether preoperative hypnosis can reduce postoperative pain, nausea, and opioid use in adolescents undergoing scoliosis surgery. Participants aged 12-18 years will receive hypnosis training before surgery. Outcomes include pain scores, nausea severity, opioid consumption, and length of hospital stay. Results will be compared to a historical control group without hypnosis.

Read the detailed description

Scoliosis surgery is associated with significant postoperative pain and nausea, often requiring opioid analgesics, which can cause adverse effects. Non-pharmacological interventions such as hypnosis have shown promise in reducing pain and anxiety in surgical patients. This quasi-experimental study with historical controls aims to assess the effect of preoperative hypnosis on postoperative outcomes in adolescents undergoing elective scoliosis surgery at St. Olavs Hospital. The intervention group will receive hypnosis training prior to surgery, while the control group consists of patients operated in 2024 without hypnosis. Data will be collected from the hospital's internal spine surgery registry and include pain scores (numeric rating scale), nausea severity, opioid consumption, mobilization time, and length of stay. Statistical analyses will compare outcomes between groups using t-tests, Mann-Whitney U tests, and chi-square tests, with significance set at p\<0.05. The study is approved by the Regional Committee for Medical and Health Research Ethics (REK Midt).

02

Conditions studied

  • Adolescent Idiopathic Scoliosis (AIS)

Browse trials for

Keywords

  • Hypnosis
  • Pain Management
  • Postoperativ Pain
  • Nausea
  • Opioid Reduction
  • Spinal Surgery
  • Adolescents
  • Non-Pharmacological Intervention
03

In context

Nausea

646 studies on the registry are indexed under Nausea; 87 are open to participants now.

This study's planned enrollment of 30 is below the median of 96 across 546 interventional studies indexed under Nausea.

Browse Nausea studies →

Lead sponsor

St. Olavs Hospital is the lead sponsor of 171 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adolescents aged 12-18 years undergoing elective scoliosis surgery
  • Provided for participation and data registration in the regional spine surgery registry

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment
  • Language barriers preventing understanding of hypnosis instructions
  • Lack of
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Interventions group

    Participants receive preoperative hypnosis training before scoliosis surgery.

    Behavioral: Hypnosis

  • No intervention
    Standard care

    Patients who underwent scoliosis surgery in 2024 without hypnosis.

Interventions

  • BehavioralHypnosis

    Participants receive preoperative hypnosis training delivered by certified psychologists. The intervention includes guided sessions and instruction in self-hypnosis techniques to reduce anxiety, pain, and nausea before and after scoliosis surgery.

06

What researchers measure

Primary outcomes

  1. Pain intensity during rest and mobilization (Numeric Rating Scale 0-10)

    Average pain score measured daily from postoperative day 0 to day 7 using a numeric rating scale (0 = no pain, 10 = worst pain).

    Time frame: Assessed daily from postoperative day 0 through postoperative day 7

Secondary outcomes

  1. Nausea severity

    Measured daily using a 0-3 scale (0 = no nausea, 3 = severe nausea)

    Time frame: Assessed daily from postoperative day 0 through postoperative day 7

  2. Total opioid consumption

    Daily dose of Oxynorm (mg) recorded during hospitalization

    Time frame: Assessed daily from postoperative day 0 through postoperative day 7

  3. Length of hospital stay

    Number of days from surgery to discharge

    Time frame: Assessed daily from postoperative day 0 through postoperative day 7

  4. Hours of mobilization per day

    Total hours mobilized per day categorized as \<1 hour, 1-5 hours, or \>5 hours

    Time frame: Assessed daily from postoperative day 0 through postoperative day 7

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because the study uses data from an internal hospital registry and includes sensitive health information. Data sharing is restricted by Norwegian privacy regulations and institutional policies.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Dec 2026, 13 months after the start.

Of 120 non-industry interventional studies with no phase under Nausea, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 28. This study's planned 13 months is close to that.

Counting every sponsor, half of 126 studies reached it within 13 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 1, 2025
First posted
Oct 2, 2026
StartActual
Nov 25, 2025
Primary completionEst.
Dec 30, 2026
CompletionEst.
Dec 30, 2026
Last update
Oct 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07854951
Lead sponsor
St. Olavs Hospital
Collaborators
National Taiwan Normal University
Responsible party
Sponsor
First posted
Oct 2, 2026
Start date
Nov 25, 2025
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Oct 2, 2026

Study contacts

Siri Winther Principal investigator, PHD
Contact
Siri.Bjorgen.Winther@stolav.no
+4772573669
Marit Johanne Resell Study coordinator, Master
Contact
Marit.Johanne.Resell@stolav.no
+4773553673

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion